Changeflow GovPing Healthcare & Life Sciences EP3448870A1: Tubulin Tyrosine Ligase Enzyme Sub...
Routine Notice Added Final

EP3448870A1: Tubulin Tyrosine Ligase Enzyme Substrates

Favicon for changeflow.com EPO Patent Bulletin - Biotech (C12N)
Published
Detected
Email

Summary

The European Patent Office published patent application EP3448870A1 on April 15, 2026, titled 'Unusual Substrates of Tubulin Tyrosine Ligase.' The patent names Forschungsverbund Berlin E.V. and Ludwig-Maximilians-Universität München as applicants, with six named inventors including Hackenberger, Schumacher, Helma, and Leonhardt. The application covers biotechnological enzyme substrates classified under C07K 1/107 and C12N 9/00, with designation extending across 32 European states.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 47 changes logged to date.

What changed

The EPO published patent application EP3448870A1, a new biotechnological patent covering unusual substrates of tubulin tyrosine ligase enzymes. The application was filed by two German research institutions and names six individual inventors, with the invention classified under multiple IPC codes covering amino acid compounds and enzymes.

For parties conducting research in enzyme biochemistry, protein engineering, or related fields, this publication establishes priority dates and defines the scope of protected subject matter. Researchers developing similar enzyme substrate technologies should review the claims to assess freedom-to-operate considerations.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

UNUSUAL SUBSTRATES OF TUBULIN TYROSINE LIGASE

Publication EP3448870A1 Kind: A1 Apr 15, 2026

Applicants

Forschungsverbund Berlin E.V., Ludwig-Maximilians-Universität München

Inventors

HACKENBERGER, Christian, SCHUMACHER, Dominik, HELMA, Jonas, LEONHARDT, Heinrich

IPC Classifications

C07K 1/107 20060101AFI20171103BHEP C12P 21/02 20060101ALI20171103BHEP C12N 9/00 20060101ALI20171103BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Notice
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3448870A1

Who this affects

Applies to
Manufacturers Research institutions
Industry sector
3254.1 Biotechnology
Activity scope
Patent grant Biotech research
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Biotechnology

Get alerts for this source

We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!